20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Aprea Therapeutics Inc (NASDAQ:APRE) shares are trading lower by 17.59% to $5.20 after the company announced pricing of a $5.5 million underwritten public offering of common stock.
What Else?
The pricing of the company's previously announced underwritten public offering of 1,050,000 shares of its common stock will be at a public offering price of $5.25 per share.
See Also: Forget Lucid Overtaking Tesla, Analyst Says EV Maker May Instead Be Headed For Titanic's Fate
In addition, Aprea says the company has granted the underwriter a 30-day option to purchase up to an additional 157,500 shares of common stock.
Aprea says the net proceeds received from the public offering will enable the company to continue developing its clinical asset, ATRN-119, its pre-clinical asset ATRN-W1051 and for general corporate purposes.
According to data from Benzinga Pro, APRE has a 52-week high of $40.80 and a 52-week low of $4.74.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!